Cost of new miracle pancreatic cancer pill sparks concern for some @CBSMornings
Cost of new miracle pancreatic cancer pill sparks concern for some  @CBSMornings
Uploaded August 2026 | Updated September 2026, 2 weeks ago
A new pill that can treat pancreatic cancer has been approved by the FDA, but the cost of the medicine is causing some people concern.

Each weekday morning, "CBS Mornings" co-hosts Gayle King and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.

Subscribe to "CBS Mornings" on YouTube: youtube.com/CBSMornings
Watch CBS News 24/7: cbsnews.com/live
Download the CBS News app: cbsnews.com/mobile
Follow "CBS Mornings" on Instagram: instagram.com/cbsmornings
Like "CBS Mornings" on Facebook: facebook.com/CBSMornings
Follow "CBS Mornings" on X: twitter.com/CBSMornings
Subscribe to our newsletter: cbsnews.com/newsletters
Try Paramount+ free: paramountplus.com/?ftag=PPM-05-10aeh8h

For video licensing inquiries, contact: licensing@veritone.com
Cost of new miracle pancreatic cancer pill sparks concern for someSaturday Sessions: Maggie Rose performs Red ShoesShoe factory fire in China kills dozens of workers13-year-old suspected of planning school shooting under arrest in Wisconsin #shortsCuban immigrant speaks out after deportation to one of the worlds most dangerous countriesDolly Parton on taking herself most seriously as a songwriter #shortsInside Notre Dame Cathedrals restoration 5 years after devastating fireHarry and Meghan returning to U K  6 years after California move #shortsRuben Gallego on becoming Arizona’s first Latino senator #shortsWhy Lindsay Clancy jurors might have asked to see the knife and pill bottlesWatch: Bear gets stuck inside familys car #shortsZac Brown on working with Dolly Parton on “Butterfly” #shorts
CBS Mornings |

Cost of new "miracle" pancreatic cancer pill sparks concern for some

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER